Publikationen in Zusammenarbeit mit Forschern von Hospital Clinic Barcelona (26)

2020

  1. Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma

    Leukemia, Vol. 34, Núm. 11, pp. 3007-3018

  2. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

    Nature Cancer, Vol. 1, Núm. 11, pp. 1066-1081

2019

  1. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D12 mantle cell lymphoma

    Blood, Vol. 133, Núm. 9, pp. 940-951

  2. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics

    Nature Communications, Vol. 10, Núm. 1

  3. Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia

    Haematologica, Vol. 104, Núm. 3, pp. 576-586

  4. Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction

    Cell Research, Vol. 29, Núm. 10, pp. 804-819

  5. The U1 spliceosomal RNA is recurrently mutated in multiple cancers

    Nature, Vol. 574, Núm. 7780, pp. 712-716

2018

  1. Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia

    Blood, Vol. 132, Núm. 22, pp. 2375-2388

  2. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

    Leukemia, Vol. 32, Núm. 3, pp. 645-653

  3. The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia

    Leukemia and Lymphoma, Vol. 59, Núm. 10, pp. 2318-2326

  4. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia

    Nature Medicine, Vol. 24, Núm. 6, pp. 868-880

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact

    Leukemia, Vol. 29, Núm. 3, pp. 598-605

  2. Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia

    Blood, Vol. 126, Núm. 2, pp. 195-202

  3. Non-coding recurrent mutations in chronic lymphocytic leukaemia

    Nature, Vol. 526, Núm. 7574, pp. 519-524

2012

  1. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

    Nature Genetics, Vol. 44, Núm. 11, pp. 1236-1242

  2. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

    Nature Genetics, Vol. 44, Núm. 1, pp. 47-52

  3. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

    Nature, Vol. 475, Núm. 7354, pp. 101-105